On July 16, 2020, Aimed Alliance submitted a comment to the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) to ask that the agencies abandon a proposed rule on Medicaid or limit the use of copay accumulators. If finalized, the rule would require that copay assistance be included the calculation of a prescription medication’s Medicaid “best price” if a health plan has implemented a copay accumulator program. This proposed rule could disincentivize drug manufacturers from providing copay assistance at all to vulnerable patients who may otherwise not be able to afford medically necessary treatments. Read our comment in full here.
Last Updated on July 16, 2020 by Aimed Alliance
